Chronic unrestrained mTOR activation may be behind AD metabolic dysfunction, causing the breakdown of the blood–brain barrier (BBB) via endothelial cell dysfunction, as well as leading to tau hyperphosphorylation, amyloid plaques formation and aggregation in the brain [38]. Here, MAPT is linked to Alzheimer disease.